As of December 31, 2017 ordinary shares KZ1C20620015 (KZ000A1CTME9, CHFM) and preferred shares KZ1P20620418 (KZ1P00000236, CHFMp) of Chimpharm to be removed from KASE official list at issuer's request

/KASE, December 12, 2017/ – Following a decision of Kazakhstan Stock Exchange (KASE) Listing Commission, as of December 31, 2017 the following securities of Chimpharm (Shymkent, hereinafter – the company) will be removed from KASE official list at their issuer's request: - ordinary shares KZ1C20620015 (KZ000A1CTME9, KASE main market, category "standard", CHFM); - preferred shares KZ1P20620418 (KZ1P00000236, KASE main market, category "standard", CHFMp). In KASE's conclusion of December 5, 2017 it is said that KASE received the following documents from the company: - an application of November 23, 2017 for a voluntary delisting of said shares as of December 31, 2017; - a copy of the minutes of the AGM of the company's shareholders dated August 1, 2017 during which a voluntary delisting of shares was approved; - a reference about holders of said shares, according to which as of August 1, 2017, CENTRAL ASIA PHARMA HOLDING B.V., holding 98.84 % of the total number of the company's outstanding shares, was a major shareholder of the company. Due to the above-mentioned and in accordance with sub-item 1) of item 1 and item 5 of chapter 3 of appendix 2.2 to KASE internal document "Listing Rules" said shares will be delisted. The mentioned shares were included in KASE official list's "B" category on March 4, 2003. Since June 1, 2017 they are in category "standard" of KASE's main market. Trades in them opened on March 4, 2003. [2017-12-12]